Abbott Laboratories (ABT)

All Comments on ABT

  • commenter
    kurt walter
    Oct 07 04:23 PM
    Getting Beyond the Fear Itself [view article]
    Buy RSU .. average in over the next few months. Reply
  • commenter
    Wadhamite
    Oct 07 03:56 PM
    Getting Beyond the Fear Itself [view article]
    Yes, there is plenty to be said for good old-fashioned thrift. Not everyone is a credit junkie. It is good to be reminded of some sound companies that are doing fine and will continue to do so. Reply
  • commenter
    woodsey
    Oct 07 01:41 PM
    Getting Beyond the Fear Itself [view article]
    Deliver us from fraud. LHR Reply
  • commenter
    Football
    Geek
    Oct 07 12:01 AM
    Dividend Aristocrats Survived September [view article]
    BAC just cut their dividend in half ... better delete them from the list Reply
  • commenter
    ajhough
    Oct 03 02:36 PM
    Dividend Aristocrats Survived September [view article]
    I own a good number of stocks in the list and have held my own quite well during September. However, the economy must be allowed to grow. Reply
  • commenter
    Whidbey
    Oct 01 02:26 PM
    Dividend Aristocrats Survived September [view article]
    Really a little goodie is it not, the dividend stocks are nice, but that hardly makes up the whole market or the economy for that matter. Having a portfolio that includes dividend paying stocks is a good idea, comes under diversification. Wholly unconnected is the clap traddle about mark to market: either we know the value or we don't, if we do not we say so. It is the truth and avoiding it is dishonest. As for your FDIC approval, it is only to help the banks hold on to deposits. But when a bank weakens the depositor who watch price know when its time to leave. You like hiding your head under bushels when the view is not your liking. That is not reasonable or supportable. Reply
  • commenter
    Dividends
    Anonymous
    Oct 01 01:01 PM
    My Website
    Dividend Aristocrats Survived September [view article]
    Great table David, thanks! Reply
  • commenter
    anarchist
    Oct 01 12:32 PM
    Dividend Aristocrats Survived September [view article]
    It may be time for "the government to gain ownership of public companies", they can't run themselves profitably, they lie and cook the books so maybe it's time to Nationalize the banking industry. The U.S. has long had heavy regulations on Utilities because it is necessary for them to serve the public and not be jacked around by price gouging and incompetence. Well we are now told that the free market economy can't function without the banking industry which has proven itself incompetent thus needing strict regulation (another word for Nationalization). Reply
  • commenter
    Kayboe
    Sep 30 03:50 PM
    Pharmaceuticals: Pfizer Is a Buy [view article]
    A slug of PFE is owned by the Fairholme Fund. Fund is managed by very sharp, Bruce Berkowitz. FAIRX is a concentrated fund, (up 13.4% annually over last 5 yrs.), and PFE represents over 10% of its current stock holdings. Yeah I own FAIRX and PFE. And I bought more PFE at the end of Monday, crash day, 9/29/08. Reply
  • commenter
    E Nuff Sed
    Sep 28 02:13 PM
    A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co. [view article]
    It is hard to judge what is hot, cold and what could blow up in your face.

    I have all three as well as Merck, Schering-Plough, Aventis and Novartis. Like insurance and finance - pharma is inherently risky - apart from pipeline and patent (expiry, litigation) risks, there is product risk (i.e. Vioxx) as well as the massive investments needed to bring a product to the market.

    Best is to buy a basket of top Pharma/Biotech - with strong dividends and diversity - they are not a bad investment in the long run with the aging population and the start of the genomic revolution ...

    Reply
  • commenter
    Tom B
    Sep 25 09:59 PM
    Pharmaceuticals: Pfizer Is a Buy [view article]
    Agree on ABT-- solid company. I may add some.

    I'm long on CVTX, GILD,RDEA, TEVA, JNJ these days.     Reply
  • commenter
    mikehav
    Sep 25 05:35 PM
    My Website
    Pharmaceuticals: Pfizer Is a Buy [view article]
    Abbott has a more diversified mix of businesses with diagnostics/nutrionals as summarized below from their last earnings report:

    -global sales growth of 14.8% to $7.3 billion (B)

    -pharmaceutical sales ($4.1B) growth of 16.7% led by Humira (a biological agent for autoimmune diseases such as rheumatoid arthritis), which experienced a 48% growth in sales for 1H08 at $1.1B with a forecast for sales of $4.3 billion for 2008

    -medical product sales ($1.4B) growth of 14.7% driven by diagnostics sales ($0.9B) growth over 17%

    -nutritional sales ($1.2B) growth of 21.3% thanks to strong results in emerging markets

    Abbott Labs reported total sales for the first half of 2008 of $14.1B with $6.5B in the USA and $7.6B internationally. The Company posted a diversified mix of healthcare business units with 56.5% of sales from prescription drugs, 16.5% from nutrional products, 12.5% from diagnostics, and about 6.5% from vascular products such as stents. The Company increased its earnings-per-share guidance from a range of $3.20 - $3.25 to $3.24 - $3.28, excluding specified items, reflecting growth of about 15% along with expected sales growth in the mid-teens for the full year.     Reply
  • commenter
    User 199792
    Sep 25 04:41 PM
    Pharmaceuticals: Pfizer Is a Buy [view article]
    All the majors down except ABT is up WHY are they up? What does the market see. Do they have lots of things in the pipelines? Reply
  • commenter
    User 269857
    Sep 25 02:32 PM
    Pharmaceuticals: Pfizer Is a Buy [view article]
    Why not just buy BMY? The yield is 6% and much better growth prospects. Reply
  • commenter
    Tom B
    Sep 25 01:33 PM
    Pharmaceuticals: Pfizer Is a Buy [view article]
    Celebrex goes off-patent 2012. PFE stock isn't bottomed yet. On the plus side, post 2012, I think things will start to look up for them. Reply
Loading...
Symbols:
Authors:
Quick Links: